Back to REGN
PINNACLE ASSOCIATES LTD → REGN
PINNACLE ASSOCIATES LTD REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$61.6M
Q3 2026
Peak value
$64.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $47.3M |
| Q4 2025 | $64.6M |
| Q1 2026 | $63.8M |
| Q2 2026 | $50.7M |
| Q3 2026 | $61.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $61.6M | 81.3K | — | — |
| Q2 2026 | $50.7M | 81.2K | — | — |
| Q1 2026 | $63.8M | 82.5K | — | — |
| Q4 2025 | $64.6M | 83.7K | — | — |
| Q3 2025 | $47.3M | 84.2K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B